The European Ombudsman has ruled in favour of a complaint filed by Testbiotech against the European Food Safety Authority (EFSA) and its approach to the 'revolving doors'. The case concerns a former senior staff member at EFSA, Dr. Suzy Renckens, who was head of the unit responsible for the risk assessment of genetically engineered plants. Dr Renckens then moved to a job at Syngenta, a company that produces and markets these plants.
Today Testbiotech is publishing a “Black List” of European Patents that have already been granted. Ten examples, granted since 2009, were selected for the list in cooperation with the Initiative “No Patents on Life”. It is shown that even chimpanzees have been patented after being genetically manipulated to suffer from epilepsy so that they can be used by the pharmaceutical industry (EP1852505).
A new publication by an international research consortium has revealed several inadequacies in current approaches to risk assessment of genetically engineered plants. The publication deals with methods used for measurement in so-called Bt-plants. These plants produce an insecticidal protein ( a so-called Bt toxin) that originates from soil bacteria (Bacillus thuringiensis). One example is maize MON810 which is cultivated in some countries in the EU, many others can be imported and used in food and feed.
Today experts from EU Member States will meet in Brussels to discuss two applications for marketing genetically engineered soybeans developed by Monsanto and Bayer. Both kinds of soybean have been engineered to be tolerant to herbicides, so that they can be sprayed directly with glyphosate (known as Roundup) or glufosinate (known as Liberty or Basta) without being damaged. As a consequence, residues from the herbicide absorbed by the plant tissues remain in the plants. The marketing applications cover import and use in food and feed.